123 related articles for article (PubMed ID: 22195906)
1. PEGylated liposomes modified with LHRH analogs for tumor targeting.
He Y; Zhang L; Song C
J Control Release; 2011 Nov; 152 Suppl 1():e29-31. PubMed ID: 22195906
[No Abstract] [Full Text] [Related]
2. Platinum (IV)-coordinate polymers for cancer drug delivery.
Yang J; Mao W; Sui M; Tang J; Shen Y
J Control Release; 2011 Nov; 152 Suppl 1():e108-9. PubMed ID: 22195784
[No Abstract] [Full Text] [Related]
3. New polymer-platinum (II) antitumor conjugates.
Xiao H; Fan Y; Liu S; Chen X; Huang Y; Jing X
J Control Release; 2011 Nov; 152 Suppl 1():e103-4. PubMed ID: 22195780
[No Abstract] [Full Text] [Related]
4. β-Cyclodextrin-based biodegradable dendrimers for drug delivery.
Tang J; Wang X; Wang X; Sui M; Mao W; Shen Y
J Control Release; 2011 Nov; 152 Suppl 1():e89-90. PubMed ID: 22195948
[No Abstract] [Full Text] [Related]
5. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
[TBL] [Abstract][Full Text] [Related]
6. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Mattheolabakis G; Nie T; Constantinides PP; Rigas B
Pharm Res; 2012 Jun; 29(6):1435-43. PubMed ID: 22072052
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect of herceptin and docetaxel in polylactide-D-α-tocopheryl polyethylene glycol succinate (PLA-TPGS) nanoparticles.
Liu Y; Feng SS
J Control Release; 2011 Nov; 152 Suppl 1():e64-5. PubMed ID: 22195930
[No Abstract] [Full Text] [Related]
8. Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.
He Y; Zhang L; Song C
Int J Nanomedicine; 2010 Sep; 5():697-705. PubMed ID: 20957221
[TBL] [Abstract][Full Text] [Related]
9. Degradable water soluble hyperbranched polymers for drug delivery.
Wang X; Tang J; Sui M; Wang X; Xu J; Shen Y
J Control Release; 2011 Nov; 152 Suppl 1():e76-8. PubMed ID: 22195940
[No Abstract] [Full Text] [Related]
10. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration.
Chaudhury A; Das S; Lee RF; Tan KB; Ng WK; Tan RB; Chiu GN
Int J Pharm; 2012 Jul; 430(1-2):167-75. PubMed ID: 22537806
[TBL] [Abstract][Full Text] [Related]
11. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y
Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531
[TBL] [Abstract][Full Text] [Related]
12. PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting.
Su W; Wang H; Wang S; Liao Z; Kang S; Peng Y; Han L; Chang J
Int J Pharm; 2012 Apr; 426(1-2):170-181. PubMed ID: 22266537
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional polyethylenimine-conjugated superparamagnetic nanoparticles for drug delivery and imaging.
Lin C; Ge J
J Control Release; 2011 Nov; 152 Suppl 1():e58-60. PubMed ID: 22195926
[No Abstract] [Full Text] [Related]
14. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
[TBL] [Abstract][Full Text] [Related]
15. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
Li C; Cui J; Wang C; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
Int J Pharm; 2008 Oct; 362(1-2):60-6. PubMed ID: 18598745
[TBL] [Abstract][Full Text] [Related]
16. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
[TBL] [Abstract][Full Text] [Related]
17. A smart polymer for drug delivery sensitive to tumor extracellular pH.
Chang G; Yu L; Ding J
J Control Release; 2011 Nov; 152 Suppl 1():e4-5. PubMed ID: 22195913
[No Abstract] [Full Text] [Related]
18. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
Cosco D; Paolino D; Cilurzo F; Casale F; Fresta M
Int J Pharm; 2012 Jan; 422(1-2):229-37. PubMed ID: 22093954
[TBL] [Abstract][Full Text] [Related]
20. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]